These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36281307)

  • 1. Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment.
    Ngonghala CN; Taboe HB; Safdar S; Gumel AB
    Appl Math Model; 2023 Feb; 114():447-465. PubMed ID: 36281307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States.
    Safdar S; Ngonghala CN; Gumel AB
    Math Biosci Eng; 2023 Jan; 20(1):179-212. PubMed ID: 36650762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical assessment of the roles of age heterogeneity and vaccination on the dynamics and control of SARS-CoV-2.
    Pant B; Gumel AB
    Infect Dis Model; 2024 Sep; 9(3):828-874. PubMed ID: 38725431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
    Mancuso M; Eikenberry SE; Gumel AB
    Infect Dis Model; 2021; 6():1110-1134. PubMed ID: 34518808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age structure and vaccine prioritization on COVID-19 in West Africa.
    Taboe HB; Asare-Baah M; Yesmin A; Ngonghala CN
    Infect Dis Model; 2022 Dec; 7(4):709-727. PubMed ID: 36097593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical assessment of control strategies against the spread of MERS-CoV in humans and camels in Saudi Arabia.
    Alatawi A; Gumel AB
    Math Biosci Eng; 2024 Jul; 21(7):6425-6470. PubMed ID: 39176403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.
    Taboe HB; Asare-Baah M; Iboi EA; Ngonghala CN
    Math Biosci; 2023 Jun; 360():108981. PubMed ID: 36803672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the SARS-CoV-2 Omicron variant dynamics in the United States with booster dose vaccination and waning immunity.
    León UA; Pérez AGC; Avila-Vales E
    Math Biosci Eng; 2023 Apr; 20(6):10909-10953. PubMed ID: 37322966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study.
    Bartsch SM; O'Shea KJ; Chin KL; Strych U; Ferguson MC; Bottazzi ME; Wedlock PT; Cox SN; Siegmund SS; Hotez PJ; Lee BY
    Lancet Public Health; 2022 Apr; 7(4):e356-e365. PubMed ID: 35276093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the dynamics of COVID-19 in the presence of Delta and Omicron variants with vaccination and non-pharmaceutical interventions.
    Saha S; Saha AK
    Heliyon; 2023 Jul; 9(7):e17900. PubMed ID: 37539217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
    Ngonghala CN; Iboi E; Eikenberry S; Scotch M; MacIntyre CR; Bonds MH; Gumel AB
    Math Biosci; 2020 Jul; 325():108364. PubMed ID: 32360770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?
    Iboi EA; Ngonghala CN; Gumel AB
    Infect Dis Model; 2020; 5():510-524. PubMed ID: 32835142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the impact of widespread respirator use in curtailing COVID-19 transmission in the USA.
    Ngonghala CN; Knitter JR; Marinacci L; Bonds MH; Gumel AB
    R Soc Open Sci; 2021 Sep; 8(9):210699. PubMed ID: 34527275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination.
    Bugalia S; Tripathi JP; Wang H
    J Math Biol; 2024 Mar; 88(4):45. PubMed ID: 38507066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.